Prime Medicine, Inc. (PRME) NASDAQ

5.54

-0.005(-0.09%)

Updated at October 01 02:57PM

Currency In USD

Prime Medicine, Inc.

Address

21 Erie Street

Cambridge, MA 02139

United States of America

Phone

617-564-0013

Sector

Healthcare

Industry

Biotechnology

Employees

214

First IPO Date

October 20, 2022

Key Executives

NameTitlePayYear Born
Dr. Jeremy S. Duffield M.D., Ph.D.Chief Scientific Officer785,5441969

Description

Prime Medicine, Inc., a biotechnology company, delivers genetic therapies to address diseases by deploying gene editing technology. It offers Prime Editors with a Prime Editor protein, comprising a fusion between a Cas protein and a reverse transcriptase enzyme; and a pegRNA, which targets the Prime Editor to a specific genomic location and provides a template for making the desired edit to the target DNA sequence. The company was incorporated in 2019 and is headquartered in Cambridge, Massachusetts.